Global Nonmydriatic Handheld Fundus Cameras Market to Reach $192.6 Million by 2026

0
56

New York, Oct. 07, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Nonmydriatic Handheld Fundus Cameras Industry” – https://www.reportlinker.com/p06032347/?utm_source=GNW
Fundus camera refers to an ophthalmic imaging device, which combines a high resolution camera with a low power microscope. Fundus cameras are typically used in applications such as fundus imaging, fluorescein angiography, paired optic disk images and external photograph. Fundus cameras are widely used in screening and diagnosis of various types of retinal disorders including diabetic retinopathy, retinal detachment, glaucoma and age-related macular degeneration. Ophthalmologists, optometrists and others use fundus cameras for screening and diagnostic purposes. A fundus or retinal camera enables practitioners to gain deeper details about the retina and also save the results for comparison and further study. Both patient and practitioner can have access to in-depth analyses of condition and subsequently take measures for treatment of the same. Fundus cameras are easy to easy devices that can capture detailed images of the retina.

A non-mydriatic fundus camera uses the reflective properties of the retina to provide details and also store images. The results achieved from non-mydriatic fundus camera are superior compared to other tools like slit lamps, and do not need pupil dilation in most cases. The camera helps in early detection and monitoring of various types of eye disorders including macular degeneration, diabetic retinopathy and glaucoma. The camera can be easily operated and requires minimal training for the operator. The benefits of the camera including a wider angle of targeted area and availability of different filter choices for image enhancement purposes. On the other hand, non-mydriatic fundus cameras do not provide stereoscopic ability, and do not detect abnormalities outside the viewing field.

Amid the COVID-19 crisis, the global market for Nonmydriatic Handheld Fundus Cameras estimated at US$122.5 Million in the year 2020, is projected to reach a revised size of US$192.6 Million by 2026, growing at a CAGR of 7.9% over the analysis period. Ophthalmology Clinics, one of the segments analyzed in the report, is projected to grow at a 8.2% CAGR to reach US$128.6 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hospitals segment is readjusted to a revised 7.6% CAGR for the next 7-year period. This segment currently accounts for a 21.5% share of the global Nonmydriatic Handheld Fundus Cameras market.

The U.S. Market is Estimated at $39 Million in 2021, While China is Forecast to Reach $21.7 Million by 2026

The Nonmydriatic Handheld Fundus Cameras market in the U.S. is estimated at US$39 Million in the year 2021. The country currently accounts for a 30.01% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$21.7 Million in the year 2026 trailing a CAGR of 9.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR while Rest of European market (as defined in the study) will reach US$23.9 Million by the close of the analysis period.

The market is being driven by steady pace of technological advancements, growing awareness about eye care, increasing geriatric population and favorable government initiatives. For instance, laws and regulations of different medical device authorities in Japan as well as the US require fundus imaging cameras to be replaced every four years. This not only maintains instrument performance but also improves treatment and diagnosis. The incorporation of digital technology and artificial intelligence are also some of the factors propelling growth of nonmydriatic handheld fundus cameras.

Since the cost of glaucoma screening, eye prosthesis and cataract surgery is covered under Medicare, it is also expected to boost the market for fundus cameras. Fundus cameras are used by optometrists, ophthalmologists and other medical professionals. These cameras are available as handheld devices or as tabletops and manufacturers are introducing new high-performance cameras. Many manufacturers are trying to introduce miniature tabletop fundus cameras, which can display live eye images to help alignment using infrared illumination. Manufacturers are also developing affordable and effective designs that include a seamless auto mosaic function, optical red-free filter, compensation lens switch, anterior para position and split aligning focus. This is also expected to drive further market growth of nonmydriatic portable fundus cameras.

North America and Europe are the leading regional markets for nonmydriatic handheld fundus cameras. In North America, the market growth is being driven by increasing geriatric population, high occurrence of diabetic retinopathy and rapid pace of technological advancements. The launch of sophisticated devices combined with the presence of important companies in this region is another factor leading to growth of fundus camera market. A 2.5% excise duty is levied on all medical devices in North America under the Patient Protection and Affordable Care Act, which can be an obstacle in the growth of fundus camera market in this region. Europe is another major market for nonmydriatic handheld fundus cameras. The high incidence of AMD, and widespread adoption of advanced healthcare technology are some other factors responsible for the increasing use of fundus cameras in Europe. Asia-Pacific and China are poised to record high growth in demand for nonmydriatic fundus cameras due to growing awareness and developing healthcare infrastructure. Increasing medical tourism is also a factor in the growth of the fundus camera market in Asia Pacific.
Select Competitors (Total 36 Featured)

  • Canon, Inc.
  • Carl Zeiss Meditec, Inc.
  • CenterVue SpA
  • Clarity Medical Systems, Inc.
  • NIDEK Co., Ltd.
  • Optomed Oy (Ltd.)
  • Optovue, Inc.
  • Topcon Medical Systems, Inc.

Read the full report: https://www.reportlinker.com/p06032347/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
Impact on Ophthalmology Services
EXHIBIT 2: US Ophthalmology Procedures Monthly Growth: 2020 Vs
2019
EXHIBIT 3: US Glaucoma and Cataract Procedures Growth: March-
April 2020
Fundus Camera Sales Hit by the Pandemic, Poised for Strong Revival
As Telehealth Makes Rapid Gains during the Pandemic, Handheld
Nonmydriatic Fundus Camera Emerge as a Vital Tool
An Introduction to Nonmydriatic Handheld Fundus Cameras
Global Market Prospects & Outlook
Developed Regions Lead, Developing Economies to Fuel Future Growth
Competition
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rise in Prevalence of Eye Disorders Present Favorable Outlook
for Nonmydriatic Portable Fundus Cameras
Key Ophthalmic Disease Statistics
EXHIBIT 4: Global Burden of Eye Diseases (In Millions): 2020
EXHIBIT 5: Prevalence of Adult Vision Impairment and Age-
Related Eye Diseases in the US
EXHIBIT 6: Global Causes of Visual Impairment: Percentage
Breakdown by Number of Cases
Portable Nonmydriatic Fundus Cameras Emerge as Effective
Screening Tool for Retinal Diseases
Aging Global Population & Rising Prevalence of Chronic Medical
Conditions Lead to an Increase in Incidence Eye Disorders,
Driving Market Gains
EXHIBIT 7: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050
EXHIBIT 8: Elderly Population (65+ Years) as a % of Total
Population by Developed, Less Developed and Least Developed
Regions: 2019 & 2030
Growing Diabetic Population and Increasing Risk of Diabetic
Retinopathy to Fuel Need for Ophthalmic Screening Devices,
Benefiting Market Growth
EXHIBIT 9: World Diabetes and Population Statistics (2019, 2030 &
2045)
EXHIBIT 10: World Diabetes Prevalence (2000-2045P)
EXHIBIT 11: Number of Adults Diagnosed with Diabetes
(in Million) by Gender for 2019, 2030 and 2045
Age-Related Macular Degeneration (AMD): A Major Vision Disorder
Presenting Opportunities for Fundus Cameras Market
EXHIBIT 12: Global Population with Age-Related Macular
Degeneration: 2016-2030
Glaucoma Prevalence and Need for Screening to Fuel Sales of
Nonmydriatic Fundus Cameras
EXHIBIT 13: Global Population with Glaucoma: 2016-2030
Handheld Non-Mydriatic Fundus Cameras Effective in Glaucoma
Detection Vs Table-Top Fundus Camera
Amidst COVID-19 Outbreak, Focus on Teleophthalmology Presents
Opportunities for Nonmydriatic Portable Fundus Cameras Market
Non-Ophthalmological Uses of Nonmydriatic Fundus Imaging to
Boost Market
Technological Advancements to Spearhead Future Market Growth
Smartphone-Based Fundus Cameras
Handheld Retinal Imaging Devices Come to the Aid During Pandemic
AI Comes to the Aid for Effective and Faster Screening and
Diagnosis of Diabetic Retinopathy Using Fundus Imaging
Rising Healthcare Spending and Focus on Quality & Affordable
Care Delivery to Boost Market Prospects
EXHIBIT 14: World Healthcare Expenditure (In US$ Trillion) for
the Years for 2017, 2019, 2021 and 2023
EXHIBIT 15: Elderly Healthcare Expenditure as a % of GDP in the
US, Europe and Japan for 1970, 2010 and 2050

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets –
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by Geographic Region – Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2021 & 2027

Table 3: World Current & Future Analysis for Ophthalmology
Clinics by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets – Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 4: World 7-Year Perspective for Ophthalmology Clinics by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

Table 5: World Current & Future Analysis for Hospitals by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 6: World 7-Year Perspective for Hospitals by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2021 & 2027

Table 7: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets – Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World 7-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 9: USA Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 10: USA 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

CANADA
Table 11: Canada Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 12: Canada 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

JAPAN
Table 13: Japan Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 14: Japan 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

CHINA
Table 15: China Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 16: China 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

EUROPE
Table 17: Europe Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by Geographic Region – France, Germany,
Italy, UK and Rest of Europe Markets – Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 18: Europe 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by Geographic Region – Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2021 & 2027

Table 19: Europe Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 20: Europe 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

FRANCE
Table 21: France Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 22: France 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

GERMANY
Table 23: Germany Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 24: Germany 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

ITALY
Table 25: Italy Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 26: Italy 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

UNITED KINGDOM
Table 27: UK Current & Future Analysis for Nonmydriatic
Handheld Fundus Cameras by End-Use – Ophthalmology Clinics,
Hospitals and Other End-Uses – Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 28: UK 7-Year Perspective for Nonmydriatic Handheld
Fundus Cameras by End-Use – Percentage Breakdown of Value Sales
for Ophthalmology Clinics, Hospitals and Other End-Uses for the
Years 2021 & 2027

REST OF EUROPE
Table 29: Rest of Europe Current & Future Analysis for
Nonmydriatic Handheld Fundus Cameras by End-Use – Ophthalmology
Clinics, Hospitals and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 30: Rest of Europe 7-Year Perspective for Nonmydriatic
Handheld Fundus Cameras by End-Use – Percentage Breakdown of
Value Sales for Ophthalmology Clinics, Hospitals and Other
End-Uses for the Years 2021 & 2027

ASIA-PACIFIC
Table 31: Asia-Pacific Current & Future Analysis for
Nonmydriatic Handheld Fundus Cameras by End-Use – Ophthalmology
Clinics, Hospitals and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 32: Asia-Pacific 7-Year Perspective for Nonmydriatic
Handheld Fundus Cameras by End-Use – Percentage Breakdown of
Value Sales for Ophthalmology Clinics, Hospitals and Other
End-Uses for the Years 2021 & 2027

REST OF WORLD
Table 33: Rest of World Current & Future Analysis for
Nonmydriatic Handheld Fundus Cameras by End-Use – Ophthalmology
Clinics, Hospitals and Other End-Uses – Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 34: Rest of World 7-Year Perspective for Nonmydriatic
Handheld Fundus Cameras by End-Use – Percentage Breakdown of
Value Sales for Ophthalmology Clinics, Hospitals and Other
End-Uses for the Years 2021 & 2027

IV. COMPETITION
Total Companies Profiled: 36
Read the full report: https://www.reportlinker.com/p06032347/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


LEAVE A REPLY

Please enter your comment!
Please enter your name here